SCHEMBL970048

SCHEMBL970048

COc1ncnc2sc3c(c12)CCN(CC(=O)N1CCN(C2CCC2)CC1)C3

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
P2RX3 P56373 3/20 0.38
RXFP1 Q9HBX9 1/20 0.37
MKNK1 Q9BUB5 5/20 0.37
HRH3 Q9Y5N1 1/20 0.37
PARP1 P09874 1/20 0.37
LIMK1 P53667 1/20 0.37
CDK8 P49336 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 2/20 0.36
EGFR P00533 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
HIF1A Q16665 1/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969943 0.81 RXFP1 (0.55) ALDH1A1P2RX3RXFP1PARP1KMT2A
SCHEMBL971049 0.81 HRH3 (0.40) ALDH1A1P2RX3HRH3PARP1KMT2A
SCHEMBL967455 0.80 PARP1 (0.41) ALDH1A1HRH3PARP1LIMK1MEN1
SCHEMBL967692 0.80 PARP1 (0.39) ALDH1A1P2RX3HRH3PARP1KMT2A
SCHEMBL1017358 0.80 PARP1 (0.41) ALDH1A1HRH3PARP1KMT2ATSHR
SCHEMBL969816 0.78 PARP1 (0.39) ALDH1A1P2RX3HRH3PARP1KMT2A
SCHEMBL966767 0.77 PARP1 (0.40) ALDH1A1HRH3PARP1KMT2AMEN1
SCHEMBL969094 0.76 PARP1 (0.44) ALDH1A1HRH3PARP1KMT2ATSHR
SCHEMBL968565 0.75 PARP1 (0.39) ALDH1A1HRH3PARP1KMT2AMEN1
SCHEMBL971597 0.75 PARP1 (0.39) ALDH1A1HRH3PARP1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 ALDH1A1 812/4885P2RX3 291/4885RXFP1 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.